Approval based on results from phase 3 VIVID-1 trial, in which end points of clinical remission and endoscopic response were met at one year ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...
Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...
Lebanon's Eli Lilly and Co. employees recently donated to the Caring Center more than 530 pounds of food which according to ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...
Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...
Michael Osso is chief executive officer of the Crohn's & Colitis Foundation. "Eli Lilly Receives FDA Approval for Crohn's Disease Treatment," at 4:40 p.m. ET, and in a subsequent update, incorrectly ...
Baltimore's school board joined districts across the country in suing drug makers over the skyrocketing costs of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback